➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
McKinsey
AstraZeneca
Medtronic
McKesson

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Patent: 10,206,956

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,206,956
Title:Compositions and methods for reducing frequency and/or severity of headache
Abstract: In one embodiment, the present invention relates to a method for reducing the frequency and/or severity of headache in a subject comprising administering to the subject a composition comprising the stromal vascular fraction or stromal cells of adipose tissue. In another embodiment, the present invention relates to a method for reducing the frequency and/or severity of headache in a subject comprising administering to the subject a composition compositing bone marrow. In another embodiment, the present invention relates to a method for reducing the frequency or severity of headache in a subject comprising administering to the subject a composition comprising adult stem cells.
Inventor(s): Bright; Ralph (Liverpool, AU), Bright; Pelin (Liverpool, AU), Hansen; Bruce (Liverpool, AU), Thomas; Wayne (Liverpool, AU)
Assignee: Rusty Property Holdings Pty Ltd. (Liverpool, AU) Amberdale Enterprises Pty Ltd. (Bar Beach, AU) Tavid Pty Ltd. (Merewether, AU)
Application Number:14/409,173
Patent Claims:see list of patent claims

Details for Patent 10,206,956

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Smith And Nephew SANTYL collagenase OINTMENT;TOPICAL 101995 001 1965-06-04   Start Trial Rusty Property Holdings Pty Ltd. (Liverpool, AU) Amberdale Enterprises Pty Ltd. (Bar Beach, AU) Tavid Pty Ltd. (Merewether, AU) 2032-06-26 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Mallinckrodt
Baxter
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.